Captrust Financial Advisors Veru Inc. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$4.35 - $15.85 $1,131 - $4,121	260 Added 11.26%	2,569 $29,000
Q1 2022 May 16, 2022	BUY	$4.55 - $6.41 $1,929 - $2,717	424 Added 22.49%	2,309 $11,000
Q4 2021 Feb 14, 2022	SELL	$5.89 - $9.73 $15,096 - $24,937	-2,563 Reduced 57.62%	1,885 $11,000
Q3 2021 Nov 16, 2021	SELL	$6.78 - $9.89 $813 - $1,186	-120 Reduced 2.63%	4,448 $38,000
Q2 2021 Aug 16, 2021	BUY	$7.24 - $11.2 $4,177 - $6,462	577 Added 14.46%	4,568 $37,000
Q1 2021 May 17, 2021	BUY	$8.05 - $20.78 $32,127 - $82,932	3,991 New	3,991 $43,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.